Lantheus Medical Imaging to Present at Jefferies 2011 Global Healthcare Conference
N. BILLERICA, Mass. (June 2, 2011) – Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that Don Kiepert, President and Chief Executive Officer, will present at the Jefferies 2011 Global Healthcare Conference on Wednesday, June 8, 2011, at 1:30 p.m. Eastern Time. Mr. Kiepert will provide an overview of the Company, its products and its clinical development pipeline.
About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medicine for more than 50 years, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The Company’s proven success in discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward new breakthrough tools for the diagnosis and management of disease. Lantheus imaging products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension, TechneLite® (Technetium Tc99m Generator), Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and ABLAVAR® (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease. Lantheus has more than 650 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Canada, Puerto Rico, and Australia. For more information, visit www.lantheus.com